A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/01/2011	US20110294792 Purine derivatives as kinase inhibitors
12/01/2011	US20110294791 Pirenzepine as an agent in cancer treatment
12/01/2011	US20110294790 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
12/01/2011	US20110294789 Compounds for rho kinase inhibition and for improving learning and memory
12/01/2011	US20110294788 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
12/01/2011	US20110294787 Substituted thiomorpholine derivatives
12/01/2011	US20110294786 Substituted bicyclic pyrimidone derivatives
12/01/2011	US20110294785 Influenza a virus inhibition
12/01/2011	US20110294784 Gamma secretase modulators
12/01/2011	US20110294782 Small molecule pak inhibitors
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294780 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
12/01/2011	US20110294779 Novel imidazopyridines
12/01/2011	US20110294778 Hepatitis c inhibitor compounds
12/01/2011	US20110294777 Beta-lactamase inhibitors
12/01/2011	US20110294776 Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases
12/01/2011	US20110294775 Novel compounds
12/01/2011	US20110294774 Identification and application of antibiotic synergy
12/01/2011	US20110294773 Cosmetic composition and hair wash
12/01/2011	US20110294772 Use of cyclosquaramide compounds as anti-tumour agents
12/01/2011	US20110294771 Treatment of muscular dystrophy
12/01/2011	US20110294770 Method for producing pharmaceutical drug particles of small particle size
12/01/2011	US20110294769 Nitrooxy derivatives of glucocorticoids
12/01/2011	US20110294768 Ophthalmic Suspension for Ocular Use
12/01/2011	US20110294767 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
12/01/2011	US20110294766 16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use
12/01/2011	US20110294765 Procedure for obtaining an aqueous dispersion of alcohols and acids from jojoba oil, processes for obtaining self-emulsified jojoba oil, aqueous dispersions and emulsions of jojoba oil in the same and pharmaceutical or cosmetic compositions comprising the same
12/01/2011	US20110294764 2-METHYLENE-19,26-NOR-(20S)-1alpha-HYDROXYVITAMIN D3
12/01/2011	US20110294763 Transdermal delivery of dicolfenac, carbamazepine and benzydamine
12/01/2011	US20110294762 Glyceryl and glycol acid compounds
12/01/2011	US20110294761 Stem cell cultures
12/01/2011	US20110294760 Compositions and Methods for Preventing Sternal Wound Infections
12/01/2011	US20110294759 Once daily formulations of tetracyclines
12/01/2011	US20110294758 Novel activators of glucokinase
12/01/2011	US20110294757 Polar lipid mixtures, their preparation and uses
12/01/2011	US20110294756 Gamma secretase modulators
12/01/2011	US20110294755 Binding of galectin-3 by low molecular weight pectin
12/01/2011	US20110294754 Novel pharmaceutical compounds
12/01/2011	US20110294753 Means and methods for counteracting muscle disorders
12/01/2011	US20110294752 Triterpene compositions and methods for use thereof
12/01/2011	US20110294751 High dosage doramectin formulation
12/01/2011	US20110294749 Diaminopyrimidinecarboxamide derivative
12/01/2011	US20110294746 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
12/01/2011	US20110294745 Solutions of lipophilic substances, especially medicinal solutions
12/01/2011	US20110294741 Use of compounds in the treatment of tau-induced cytotoxicities
12/01/2011	US20110294737 Terminally-differentiated anucleate platelet progeny generation
12/01/2011	US20110294732 Erythropoletin complementation or replacement
12/01/2011	US20110294726 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
12/01/2011	US20110294718 Dipeptoid prodrugs and the use thereof
12/01/2011	US20110294717 Therapeutic Polymeric Nanoparticle Compositions with High Glass Transition Temperature or High Molecular Weight Copolymers
12/01/2011	US20110294694 Methods for detecting, diagnosing and treating human renal cell carcinoma
12/01/2011	US20110294408 Method and composition for washing poultry during processing
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110293759 Nutritional supplement for recovery, repair, and maintenance
12/01/2011	US20110293755 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
12/01/2011	US20110293751 Composition for Treatment of Skin
12/01/2011	US20110293750 Activated wnt-beta-catenin signaling in melanoma
12/01/2011	US20110293748 Combined preparation for treating sepsis
12/01/2011	US20110293746 Modulation of Gsk-3Beta and Method of Treating Proliferative Disorders
12/01/2011	US20110293745 Aurora kinase inhibitors
12/01/2011	US20110293744 Benzoxazole inhibitors of poly(adp-ribose)polymerase
12/01/2011	US20110293740 Treatment system and method for osteopenia and osteoporosis using non-synthetic bio-available compounds
12/01/2011	US20110293734 New plant derived seed extract rich in essentially fatty acids derived from salvia hispanica l. seed: composition of matter, manufacturing process and use
12/01/2011	US20110293733 Self-assembling nanoparticle drug delivery system
12/01/2011	US20110293731 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
12/01/2011	US20110293730 Polylactide nanoparticles
12/01/2011	US20110293729 Novel composition based on gamma-hydroxybutyric acid
12/01/2011	US20110293724 Enzyme Treatment of Foodstuffs for Celiac Sprue
12/01/2011	US20110293721 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
12/01/2011	US20110293720 Progestin-containing drug delivery system
12/01/2011	US20110293719 Novel compounds and compositions and methods of use
12/01/2011	US20110293718 Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same
12/01/2011	US20110293717 Compacted moxifloxacin
12/01/2011	US20110293716 Pharmaceutical formulation containing ibuprofen and codeine
12/01/2011	US20110293715 Pharmaceutical Formulation and Process for Its Preparation
12/01/2011	US20110293713 Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
12/01/2011	US20110293711 Utilization of Dialkylfumarates
12/01/2011	US20110293708 Process for preparing purified nucleic acid and the use thereof
12/01/2011	US20110293703 Aminoalcohol lipidoids and uses thereof
12/01/2011	US20110293702 Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS
12/01/2011	US20110293698 Reagents and Methods for Treating Cancer
12/01/2011	US20110293696 Compositions and methods for treating bruises
12/01/2011	US20110293695 Amphoteric liposomes
12/01/2011	US20110293694 Quantum unit of inheritance vector therapy method
12/01/2011	US20110293693 Quantum unit of inheritance vector therapy
12/01/2011	US20110293691 Multimodal adhesion barrier
12/01/2011	US20110293690 Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof
12/01/2011	US20110293689 Immobilized biologically active entities having a high degree of biological activity
12/01/2011	US20110293681 Hand sanitizing patch having an integrally bonded antimicrobial
12/01/2011	US20110293676 Oral Cephalotaxine Dosage Forms
12/01/2011	US20110293674 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION
12/01/2011	US20110293673 Oral film-form base and oral film-form preparation
12/01/2011	US20110293672 Pancreatic tumour treatment
12/01/2011	US20110293670 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
12/01/2011	US20110293668 Oral odor control method and product
12/01/2011	US20110293664 Chlamydia antigens and uses thereof
12/01/2011	US20110293658 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
12/01/2011	US20110293654 SUBSTITUTED CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
12/01/2011	US20110293653 Antagonists of mir-155 for the treatment of inflammatory liver disease
12/01/2011	US20110293652 Chimeric ospa genes, proteins, and methods of use thereof

1 ... 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 ... 7860